# OnCo record eortc-62012 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/eortc-62012/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "eortc-62012", "NCT00061984" ;
  schema:name "EORTC 62012"@en ;
  schema:description "Adding ifosfamide to doxorubicin shrank more sarcomas and delayed progression but did not significantly lengthen life, so doxorubicin alone stayed the standard unless a tumour needs to shrink."@en ;
  schema:url <https://onco.cc/trials/eortc-62012/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT00061984>, <https://doi.org/10.1016/S1470-2045(14)70063-4> ;
  onco:status "completed" ;
  onco:tag "subtype-page" ;
  onco:phase "3" ;
  onco:cancers <https://onco.cc/cancers/extremity-soft-tissue-sarcoma/>, <https://onco.cc/cancers/undifferentiated-pleomorphic-sarcoma/>, <https://onco.cc/cancers/malignant-peripheral-nerve-sheath-tumour/>, <https://onco.cc/cancers/sarcoma/> ;
  onco:drugs <https://onco.cc/drugs/doxorubicin/>, <https://onco.cc/drugs/ifosfamide/> .